PROCTER & GAMBLE HEALTH LTD.

NSE : PGHLBSE : 500126ISIN CODE : INE199A01012Industry : Pharmaceuticals & DrugsHouse : Merck - MNC
BSE6289.35-55.55 (-0.88 %)
PREV CLOSE ( ) 6344.90
OPEN PRICE ( ) 6345.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 566
TODAY'S LOW / HIGH ( )6250.00 6380.00
52 WK LOW / HIGH ( )3750 7499.95
NSE6281.25-58.1 (-0.92 %)
PREV CLOSE( ) 6339.35
OPEN PRICE ( ) 6355.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 11190
TODAY'S LOW / HIGH( ) 6243.45 6410.75
52 WK LOW / HIGH ( )3810.25 7500
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 26-04 1967
Management Info
Suresh N Talwar - Chairman Milind Thatte - Managing Director
Registered Office

Address Godrej One, 8th Floor,Pirojshanagar,Eastern Express Highway, Vikhroli (East),
Mumbai,
Maharashtra-400079

Phone 022 6866 9000

Email investorgrievance.im@pg.com

Website www.pghealthindia.com

Registrars Details
K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
28Nov Procter & Gamble Health informs about
Procter & Gamble Health has informed that the 53rd Annual General Me..
20Mar Procter & Gamble Health informs about
Procter & Gamble Health has informed about the loss/ misplacement of..
17Mar Procter & Gamble Health informs about
Procter & Gamble Health has informed that the Company enclosed votin..
25Jan Procter & Gamble Health informs about
Procter & Gamble Health has been informed by shareholder, Yogesh Bab..
22Jan Procter & Gamble Health informs about
Procter & Gamble Health has been informed by the shareholder, Somdat..
Financials
Rs. in Millions
QTR Dec 20 ANNUAL 19
Net Profit678.81587.58
Gross Profit 864.3 2343.59
Operating Profit 944.72515.24
Net Sales 2402.29265.98
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Astrazeneca Pharma I (BSE)
 3905.70 (8.77%)
M.Cap (Rs. in Cr)9764.25
Neuland Laboratories (BSE)
 2674.85 (7.69%)
M.Cap (Rs. in Cr)3431.80
Dr. Reddys Lab (BSE)
 5153.95 (3.69%)
M.Cap (Rs. in Cr)85710.82
Abbott India (BSE)
 14860.60 (1.08%)
M.Cap (Rs. in Cr)31577.74
Pfizer (BSE)
 5480.60 (2.86%)
M.Cap (Rs. in Cr)25072.50
Shareholding Pattern
PROMOTERS 51.82%
NON-INSTITUTION 30%
MUTUAL FUNDS/UTI 6.13%
FI/BANKS/INSURANCE 5.34%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016

INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075,9768009000, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.